{"database": "lobbying", "table": "lobbying_activities", "rows": [[2682540, "6b197edb-0b07-43b6-bff8-e4277355611e", "Q3", "MARSHALL & POPP, LLC", 401105121, "3M COMPANY", 2021, "third_quarter", "DIS", "Issues related to the COVID-19 pandemic, including:\nS.1260: United States Innovation and Competition Act of 2021.\nBudget reconciliation recommendations reported by House committees pursuant to S.Con.Res. 14.\nEfforts to combat counterfeits and price gouging during COVID.\nEfforts to encourage domestic production of PPE.\nIssues related to the Strategic National Stockpile.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2021-10-16T08:31:22.893000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2682540"], "units": {}, "query_ms": 1.6728260088711977, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}